| 1 |
Siegel RL，Miller KD，Jemal A．Cancer statistics, 2019[J]．CA Cancer J Clin，2019，69（1）：7-34．
|
| 2 |
Gao S，Li N，Wang S，et al．Lung Cancer in People's Republic of China[J]．J Thorac Oncol，2020，15（10）：1567-1576．
|
| 3 |
Cahan WG．Radical lobectomy[J]．J Thorac Cardiovasc Surg，1960，39：555-572．
|
| 4 |
Strand TE，Rostad H，Møller B，et al．Survival after resection for primary lung cancer: a population based study of 3211 resected patients[J]．Thorax，2006，61（8）：710-715．
|
| 5 |
Qiu C，Wang G，Xu J，et al．Sublobectomy versus lobectomy for stage I non-small cell lung cancer in the elderly[J]．Int J Surg，2017，37：1-7．
|
| 6 |
Yi E，Cho S，Kim K，et al．Comparison of survival outcomes between sublobar resection and lobectomies in early-stage lung adenocarcinoma by propensity score matching analysis[J]．Indian J Thorac Cardiovasc Surg，2020，36（4）：382-387．
|
| 7 |
Wald O，Sadeh BM，Bdolah-Abram T，et al．Outcomes of sublobar resection vs lobectomy for invasive clinical stage T1N0 non-small-cell lung cancer: A propensity-match analysis[J]．Cancer Rep (Hoboken)，2021，4（3）：e1339．
|
| 8 |
Nomori H，Yamazaki I，Machida Y，et al．Lobectomy versus segmentectomy: a propensity score-matched comparison of postoperative complications, pulmonary function and prognosis[J]．Interact Cardiovasc Thorac Surg，2022，34（1）：57-65．
|
| 9 |
Zhang B，Liu R，Ren D，et al．Comparison of Lobectomy and Sublobar Resection for Stage IA Elderly NSCLC Patients (≥70 Years): A Population-Based Propensity Score Matching's Study[J]．Front Oncol，2021，11：610638．
|
| 10 |
Saji H，Okada M，Tsuboi M，et al．Segmentectomy versus lobectomy in small-sized peripheral non-small-cell lung cancer (JCOG0802/WJOG4607L): a multicentre, open-label, phase 3, randomised, controlled, non-inferiority trial[J]．Lancet，2022，399（10335）：1607-1617．
|
| 11 |
Altorki N，Wang X，Kozono D，et al．Lobar or Sublobar Resection for Peripheral Stage IA Non-Small-Cell Lung Cancer[J]．N Engl J Med，2023，388（6）：489-498．
|
| 12 |
Liang W，He J，Shen Y，et al．Impact of Examined Lymph Node Count on Precise Staging and Long-Term Survival of Resected Non-Small-Cell Lung Cancer: A Population Study of the US SEER Database and a Chinese Multi-Institutional Registry[J]．J Clin Oncol，2017，35（11）：1162-1170．
|
| 13 |
Akinbobola O，Ray MA，Fehnel C，et al．Institution-Level Evolution of Lung Cancer Resection Quality With Implementation of a Lymph Node Specimen Collection Kit[J]．J Thorac Oncol，2023，18（7）：858-868．
|
| 14 |
Nagata Y，Hiraoka M，Shibata T，et al．Prospective Trial of Stereotactic Body Radiation Therapy for Both Operable and Inoperable T1N0M0 Non-Small Cell Lung Cancer: Japan Clinical Oncology Group Study JCOG0403[J]．Int J Radiat Oncol Biol Phys，2015，93（5）：989-996．
|
| 15 |
van Meerbeeck JP，Kramer GW，Van Schil PE，et al．Randomized controlled trial of resection versus radiotherapy after induction chemotherapy in stage IIIA-N2 non-small-cell lung cancer[J]．J Natl Cancer Inst，2007，99（6）：442-450．
|
| 16 |
Albain KS，Swann RS，Rusch VW，et al．Radiotherapy plus chemotherapy with or without surgical resection for stage III non-small-cell lung cancer: a phase III randomised controlled trial[J]．Lancet，2009，374（9687）：379-386．
|
| 17 |
Martins RG，D'Amico TA，Loo BW Jr，et al．The management of patients with stage IIIA non-small cell lung cancer with N2 mediastinal node involvement[J]．J Natl Compr Canc Netw，2012，10（5）：599-613．
|
| 18 |
Chang JY，Mehran RJ，Feng L，et al．Stereotactic ablative radiotherapy for operable stage I non-small-cell lung cancer (revised STARS): long-term results of a single-arm, prospective trial with prespecified comparison to surgery[J]．Lancet Oncol，2021，22（10）：1448-1457．
|
| 19 |
Howington JA，Blum MG，Chang AC，et al．Treatment of stage I and II non-small cell lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines[J]．Chest，2013，143（5 Suppl）：e278S-e313S．
|
| 20 |
Suzuki K，Asamura H，Kusumoto M，et al．"Early" peripheral lung cancer: prognostic significance of ground glass opacity on thin-section computed tomographic scan[J]．Ann Thorac Surg，2002，74（5）：1635-1639．
|
| 21 |
Suzuki K，Koike T，Asakawa T，et al．A prospective radiological study of thin-section computed tomography to predict pathological noninvasiveness in peripheral clinical IA lung cancer (Japan Clinical Oncology Group 0201)[J]．J Thorac Oncol，2011，6（4）：751-756．
|
| 22 |
Suzuki K，Watanabe SI，Wakabayashi M，et al．A single-arm study of sublobar resection for ground-glass opacity dominant peripheral lung cancer[J]．J Thorac Cardiovasc Surg，2022，163（1）：289-301.e2．
|
| 23 |
Aokage K，Saji H，Suzuki K，et al．A non-randomized confirmatory trial of segmentectomy for clinical T1N0 lung cancer with dominant ground glass opacity based on thin-section computed tomography (JCOG1211)[J]．Gen Thorac Cardiovasc Surg，2017，65（5）：267-272．
|
| 24 |
中华医学会肿瘤学分会，中华医学会杂志社．中华医学会肺癌临床诊疗指南(2023版)[J]．中华医学杂志，2023，103（27）：2037-2074．
|
| 25 |
Darling GE，Allen MS，Decker PA，et al．Randomized trial of mediastinal lymph node sampling versus complete lymphadenectomy during pulmonary resection in the patient with N0 or N1 (less than hilar) non-small cell carcinoma: results of the American College of Surgery Oncology Group Z0030 Trial[J]．J Thorac Cardiovasc Surg，2011，141（3）：662-670．
|
| 26 |
Hishida T，Miyaoka E，Yokoi K，et al．Lobe-Specific Nodal Dissection for Clinical Stage I and II NSCLC: Japanese Multi-Institutional Retrospective Study Using a Propensity Score Analysis[J]．J Thorac Oncol，2016，11（9）：1529-1537．
|
| 27 |
Adachi H，Sakamaki K，Nishii T，et al．Lobe-Specific Lymph Node Dissection as a Standard Procedure in Surgery for Non-Small Cell Lung Cancer: A Propensity Score Matching Study[J]．J Thorac Oncol，2017，12（1）：85-93．
|
| 28 |
Zhang Y，Fu F，Wen Z，et al．Segment Location and Ground Glass Opacity Ratio Reliably Predict Node-Negative Status in Lung Cancer[J]．Ann Thorac Surg，2020，109（4）：1061-1068．
|
| 29 |
Zhang Y，Deng C，Zheng Q，et al．Selective Mediastinal Lymph Node Dissection Strategy for Clinical T1N0 Invasive Lung Cancer: A Prospective, Multicenter, Clinical Trial[J]．J Thorac Oncol，2023，18（7）：931-939．
|
| 30 |
Edwards JG，Chansky K，Van Schil P，et al．The IASLC Lung Cancer Staging Project: Analysis of Resection Margin Status and Proposals for Residual Tumor Descriptors for Non-Small Cell Lung Cancer[J]．J Thorac Oncol，2020，15（3）：344-359．
|